"Synergy Search" Lies Behind AZ's Combined CV, Diabetes and Renal Ops
Executive Summary
The head of AstraZeneca's newly combined cardiovascular, metabolic diseases and renal franchise says his mission is to align and find synergies for the three therapeutic areas.